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INTRODUCTION

METHODS

Antibiotics have been crucial in the medical advancements
towards decreasing mortality due to microbial infections;
however, a group has emerged as multidrug resistant infections
arising in healthcare settings, also called nosocomial pathogens7.
Antibiotics work to eliminate bacterial infections by interrupting
protein synthesis or DNA replication, which essentially renders
the bacteria inactive3. However, pathogenic bacteria are able to
adapt and resist antibiotics by random mutations or transference
of resistant genetic material from other bacteria3. The ESKAPE
pathogens, which is an acronym for the six bacterial strains
Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter spp., are resistant to antimicrobial
agents and contribute to increased mortality rates among
nosocomial infections4,7. Identified by World Health Organization
(WHO) as dangerous pathogens, ESKAPE bacterial strains pose a
public health threat because their antibiotic resistance increases
health care costs and decreases the ability to effectively treat these
infections4-5,9. The health-care field acknowledges the dire need
for developing new treatment strategies to reduce ESKAPE
pathogens in prevalence and mortality risk with new research
studies, like this one.
Further investigative research needs to focus on safe, bacterial
related strains that are related to the ESKAPE strains and nonpathogenic. Generally, bacteria are prokaryotic microbes with cell
walls that can be beneficial or pathogenic to human beings. They
replicate through binary fission on either cultured planktonic or
agar plated surfaces3. This research study is conducted on
Escherichia coli, a safe-relative of Klebsiella pneumoniae, and on
Bacillus subtilis. E. coli are single or paired rods that are Gramnegative and motile, usually found within the intestines of animal
hosts8. B. subtilis, is rod-shaped, Gram-positive that forms spores
under stressful conditions, which contributes to their motile
abilities6. Various treatment strategies are underway to combat
multi-drug resistant bacteria, such as antibiotics in combination,
and applying silver nanoparticles or photodynamic light therapy4.
A new research program, Tiny Earth Project Initiative (TEPI), has
emerged to find antibiotic options to stop the ESKAPE pathogens
while discovering vital research about lost soil sustainability

Fig. 1. The four
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TEPI is an international research network of students and
professors that work to accomplish three goals: student-originated
research, identifying novel antibiotic-producing microbes in local
soil samples, and understanding how to maintain microbial
diversity while combating soil erosion3. The purpose of this
research project is to identify potential antibiotic-producing
bacteria from local soil samples to take the next steps in
developing new antibiotics to combat ESKAPE-related strains,
such as Escherichia coli, and Bacillus subtilis.

Unless described otherwise, the bacterial strains and protocols used
in this study were provided by the Tiny Earth Project Initiative
(TEPI) 3.
▪ On January 9th, 2020, a soil sample was collected from Duck
Creek Park, Bettendorf, IA. (Latitude 41.54; Longitude, -90.53).
▪ A 1.65 gram dry soil sample was transformed into a slurry mix.
From the slurry, serial dilutions of the mix were plated onto three
types of media: LB agar, 10% TSA, and PDA. The bacterial
cultures were incubated at 28°C-30°C for 24-48 hours.
▪ Master plates were created by streaking bacterial colonies from
the serial dilution plates onto their respective media.
▪ Then, the same bacterial colonies were streaked onto petri dishes
with spread bacterial strains of Bacillus subtilis and Escherichia
coli to test for potential antibiotic producers.
▪ Once antibiotic producers were identified and confirmed, colony
PCR was completed and gel electrophoresis isolated DNA of the
bacterial colonies. DNA was removed from the gel and purified
for further 16S rRNA sequencing at University of Iowa, Iowa
Institute of Human Genetics.
▪ NCBI BLAST analyzed the data, identifying a genus.

RESULTS

RESULTS (CONTINUED)
Table 1. NCBI Blast Program 16S rRNA Genetic Sequencing Analysis of Soil
Isolate CP-8-LB-B. subtilis
Query
Percent
E value
cover
Identity
Bacillus mobilis strain MCCC 1A05942

99%

0

99.72%

Bacillus thuringiensis strain NBRC 101235

99%

0

99.65%

Bacillus toyonensis strain BCT-7112

99%

0

99.65%

Bacillus thuringiensis strain ATCC 10792

99%

0

99.65%

Bacillus thuringiensis strain IAM 120777
99%
0
99.65%
Table 2. NCBI Blast Program 16S rRNA Genetic Sequencing Analysis of Soil
Isolate CP-26-TSA-B. subtilis
Query
Percent
E value
cover
Identity
Bacillus mobilis strain MCCC 1A05942

98%

0

99.14%

Bacillus thuringiensis strain NBRC 101235

98%

0

98.93%

Bacillus toyonensis strain BCT-7112

98%

0

98.93%

Bacillus thuringiensis strain ATCC 10792

98%

0

98.93%

Bacillus thuringiensis strain IAM 120777

98%

0

98.93%

The tables above show the NCBI BLAST program analysis for the 16S rRNA
sequence after the primers 27F and 1492R for both soil isolates, CP-8-LB-B.
subtilis and CP-26-TSA-B. subtilis, and determined them to be of the Bacillus
genus2. Query coverage indicates the percent of the inputted sample compared
against other known bacteria. Percent identity indicates the percentage of
identical base pairs of the inputted sample against the matched database
bacteria. The probability that the hits in the database are pulled out by random
are found with any numerical value in the E value. Both soil isolates show
high validity indicated by above 98% on QC and PI, and 0 in the E value.

DISCUSSION
NCBI BLAST analysis determined the bacterial strains were likely
from the genus of Bacillus, which makes sense as an antibiotic
producer pulled from the soil2. Both soil isolates, CP-8-LB-B.
subtilis and CP-26-TSA-B. subtilis, demonstrated antibiotic abilities
when halos or zones of inhibition were produced against B. subtilis.
Bacillus lies within the phyla of Firmicutes and ranges 0-7% in
being found in soil samples with a mean contribution of 2%1.
Fig. 2. Three soil isolates produced zones of inhibition (halos) when
tested for antibiotic producing abilities against B. subtilis and E. coli:
CP-1-LB-B.subtilis, CP-8-LB-B. subtilis, and CP-26-LB-B. subtilis. Soil
isolate 8 on LB and 26 on TSA produced bigger halos than 1 on LB,
which indicates further testing confirmation on soil isolate 1 is
necessary. Both CP-8-LB-B. subtilis and CP-26-TSA-B. subtilis were
effective against Bacillus subtilis, yet showed no halo effects or zones of
inhibition against E. coli.

Future direction will look into understanding the organic molecular
structure of Bacillus using NMR spectrometry3. Also, researchers
will analyze other soil samples in the area of the current soil sample
to obtain further understanding of local soil bacteria.
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